Answers are grounded in this paper and cite their sources.
### Key messages > This paper explains the importance of extrapolating beyond the end of trials to estimate the long term benefits associated with new treatments, why this is done, and the limitations of various approaches. Policy makers worldwide use economic evaluation to inform decisions when
No takes yet. Share an insight, caveat, or question.
Latimer et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: